seed
Stage
1
Investors
About
Rejuvenation Technologies develops proprietary therapies that safely extend telomeres in human cells using modified mRNA and targeted delivery to potentially reverse cellular aging and treat age-related diseases.
Explore Rejuvenation Technologies's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.